Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement

Magnetic Resonance in Medicine

Volumn 72, Issue 3, 2014, Pages 816-822

  Mendes, Jason ^a   Parker, Dennis L ^a   McNally, Scott ^a   Dibella, Ed ^a   Bolster, Bradley D ^b   Treiman, Gerald S ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Siemens Healthcare   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

carotid inflammation; carotid plaque; dynamic contrast enhanced; plaque progression

Indexed keywords

IMAGE ENHANCEMENT; RECOVERY;

2-D SLICE; ARTERIAL INPUT FUNCTION; CAROTID INFLAMMATION; CAROTID PLAQUES; CONTRAST AGENT; DYNAMIC CONTRAST-ENHANCED; DYNAMIC CONTRAST-ENHANCED IMAGING; HIGH TEMPORAL RESOLUTION; PLAQUE PROGRESSION; RECOVERY TIME;

DYNAMIC CONTRAST ENHANCED MRI;

GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ARTICLE; ATTENUATION; CAROTID ARTERY DISEASE; CAROTID ARTERY FLOW; CONTRAST ENHANCEMENT; HUMAN; INTERNAL CAROTID ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; THREE DIMENSIONAL IMAGING; ANALOGS AND DERIVATIVES; CAROTID ARTERY DISEASES; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES;

CAROTID ARTERY DISEASES; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MEGLUMINE; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PHANTOMS, IMAGING;

EID: 84920285415     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24993     Document Type: Article

References (39)

1. Fryer JA, Myers PC, Appleberg M,. Carotid intraplaque hemorrhage: the significance of neovascularity. J Vasc Surg 1987; 6: 341-349.
2. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J,. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061.
3. Barger AC, Beeuwkes R3, Lainey LL, Silverman KJ,. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310: 175-177.
4. Moreno PR, Purushothaman K, Sirol M, Levy AP, Fuster V,. Neovascularization in human atherosclerosis. Circulation 2006; 113: 2245-2252.
5. de Boer OJ, van der Wal AC, Teeling P, Becker AE,. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?. Cardiovasc Res 1999; 41: 443-449.
6. Langheinrich AC, Kampschulte M, Buch T, Bohle RM,. Vasa vasorum and atherosclerosis-Quid novi?. Thromb Haemost 2007; 97: 873-879.
7. Ramos MA, Kuzuya M, Esaki T, Miura S, Satake S, Asai T, Kanda S, Hayashi T, Iguchi A,. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998; 18: 1188-1196.
8. McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJ, Bell PR, Naylor AR, Brindle NP,. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999; 30: 261-268.
9. Kumamoto M, Nakashima Y, Sueishi K,. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995; 26: 450-456.
10. Lappalainen H, Laine P, Pentikainen MO, Sajantila A, Kovanen PT,. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004; 24: 1880-1885.
11. Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, Yuan C,. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003; 107: 851-856.
12. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C,. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006; 241: 459-468.
13. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS,. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008; 59: 507-514.
14. Kerwin WS, Zhao X, Yuan C, Hatsukami TS, Maravilla KR, Underhill HR, Zhao X,. Contrast-enhanced MRI of carotid atherosclerosis: dependence on contrast agent. J Magn Reson Imaging 2009; 30: 35-40.
15. Dong L, Kerwin WS, Chen H, Chu B, Underhill HR, Neradilek MB, Hatsukami TS, Yuan C, Zhao X,. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum - evaluation by using dynamic contrast-enhanced MR imaging. Radiology 2011; 260: 224-231.
16. Chen H, Li F, Zhao X, Yuan C, Rutt B, Kerwin WS,. Extended graphical model for analysis of dynamic contrast-enhanced MRI. Magn Reson Med 2011; 66: 868-878.
17. Calcagno C, Vucic E, Mani V, Goldschlager G, Fayad ZA,. Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits. J Magn Reson Imaging 2010; 32: 191-198.
18. Parker GJM, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC,. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56: 993-1000.
19. Gaens ME, Backes WH, Rozel S, et al. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation. Radiology 2013; 266: 271-279.
20. Fritz-Hansen T, Rostrup E, Larsson HB, Sondergaard L, Ring P, Henriksen O,. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996; 36: 225-231.
21. Port RE, Knopp MV, Brix G,. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn Reson Med 2001; 45: 1030-1038.
22. Henderson E, Rutt BK, Lee TY,. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998; 16: 1057-1073.
23. Schabel MC, Fluckiger JU, DiBella EVR,. A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI. I. Simulations. Phys Med Biol 2010; 55: 4783-4806.
24. Cheng HM,. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 2008; 28: 736-743.
25. Kim D, Axel L,. Multislice, dual-imaging sequence for increasing the dynamic range of the contrast-enhanced blood signal and CNR of myocardial enhancement at 3T. J Magn Reson Imaging 2006; 23: 81-86.
26. Gatehouse PD, Elkington AG, Ablitt NA, Yang G, Pennell DJ, Firmin DN,. Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance. J Magn Reson Imaging 2004; 20: 39-45.
27. Breton E, Kim D, Chung S, Axel L,. Quantitative contrast-enhanced first-pass cardiac perfusion MRI at 3 tesla with accurate arterial input function and myocardial wall enhancement. J Magn Reson Imaging 2011; 34: 676-684.
28. Calcagno C, Robson PM, Ramachandran S, Mani V, Kotys-Traughber M, Cham M, Fischer SE, Fayad ZA,. SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries. J Cardiovasc Magn Reson 2013; 15: 42.
29. Krejza J, Arkuszewski M, Kasner SE, Weigele J, Ustymowicz A, Hurst RW, Cucchiara BL, Messe SR,. Carotid artery diameter in men and women and the relation to body and neck size. Stroke 2006; 37: 1103-1105.
30. Buckley DL,. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002; 47: 601-606.
31. Murase K,. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004; 51: 858-862.
32. Kim D,. Influence of the k-space trajectory on the dynamic T1-weighted signal in quantitative first-pass cardiac perfusion MRI at 3T. Magn Reson Med 2008; 59: 202-208.
33. Chen L, Adluru G, Schabel MC, McGann CJ, Dibella EVR,. Myocardial perfusion MRI with an undersampled 3D stack-of-stars sequence. Med Phys 2012; 39: 5204-5211.
34. Tate Q, Kim S, Treiman G, Parker DL, Hadley JR,. Increased vessel depiction of the carotid bifurcation with a specialized 16-channel phased array coil at 3T. Magn Reson Med 2013; 69: 1486-1493.
35. Kirchin MA, Pirovano GP, Spinazzi A,. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998; 33: 798-809.
36. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
37. Zhang X, Petersen ET, Ghariq E, De Vis JB, Webb AG, Teeuwisse WM, Hendrikse J, van Osch MJP,. In vivo blood T(1) measurements at 1.5 T, 3 T, and 7 T. Magn Reson Med 2013; 70: 1082-1086.
38. Ishida M, Sakuma H, Murashima S, Nishida J, Senga M, Kobayasi S, Takeda K, Kato N,. Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imaging 2009; 29: 205-210.
39. Kamenskiy AV, Dzenis YA, Mactaggart JN, Desyatova AS, Pipinos II,. In vivo three-dimensional blood velocity profile shapes in the human common, internal, and external carotid arteries. J Vasc Surg 2011; 54: 1011-1020.